Growing community of inventors

Berlin, Germany

Jörg Willuda

Average Co-Inventor Count = 3.75

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 60

Jörg WilludaAndreas Plückthun (3 patents)Jörg WilludaAnnemarie Honegger (3 patents)Jörg WilludaGerhard Siemeister (2 patents)Jörg WilludaUlrich Klar (2 patents)Jörg WilludaMarkus Berger (2 patents)Jörg WilludaAndreas Menrad (2 patents)Jörg WilludaKlaus Bosslet (2 patents)Jörg WilludaJörg Willuda (5 patents)Andreas PlückthunAndreas Plückthun (19 patents)Annemarie HoneggerAnnemarie Honegger (7 patents)Gerhard SiemeisterGerhard Siemeister (77 patents)Ulrich KlarUlrich Klar (77 patents)Markus BergerMarkus Berger (37 patents)Andreas MenradAndreas Menrad (23 patents)Klaus BossletKlaus Bosslet (4 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. University of Zürich (3 from 97 patents)

2. Schering Aktiengesellschaft (2 from 1,384 patents)


5 patents:

1. 8137932 - Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment

2. 7858088 - Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment

3. 7335775 - Effector conjugates, process for their production and their pharmaceutical use

4. 7129254 - Effector conjugates, process for their production and their pharmaceutical use

5. 7033798 - Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/1/2026
Loading…